Cash is trash: the best stocks to buy to beat 10% inflation

It’s time I put my spare cash to work to protect against the 10.1% inflation rate. Here’s how I’m choosing the best stocks to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young woman wearing a headscarf on virtual call using headphones

Image source: Getty Images

Inflation is high! The prices of almost all the goods used to calculate overall inflation rates have increased. At this rate, cash sitting in my bank account won’t stretch nearly as far next year as it will today. That’s why I think that identifying stocks to buy that might grow my savings faster than the rate of prices is a more pressing matter than ever.

But which stocks do I think will thrive in a climate where prices are rising? Here are two I decided to add to my portfolio last week.

British American Tobacco

British American Tobacco (LSE:BATS) is up an impressive 19% year to date as I write.

Research shows that cigarettes are slightly ‘price inelastic’. This means that if the price of cigarettes increases, the following drop in demand will be less significant by comparison. But much of that lost demand will be likely to substitute cigarettes for oral and vapour-based nicotine products.

British American Tobacco has all these types of products in its portfolio. Raising its prices to protect its profit margins from inflation shouldn’t see demand drop too harshly. The tobacco giant also boasts a 6.5% dividend yield. Topping that yield up with share price growth may quickly find my investment keeping up with inflation.

However, British American Tobacco does have a high level of debt leaving it exposed to rising interest rates. Currently, the company is working on reducing its debt but whether that continues is not guaranteed.

Unite Group

When prices rise and consumers become strapped for cash, you can expect demand for cheap housing to rise. This is particularly the case for students seeking rented accommodation, largely supported by their limited student loans.

Unite Group (LSE:UTG) is the UK’s largest owner and developer of purpose-built student accommodation.

As I write, the group’s share price has been hit hard so far this year, down 25% year to date.

Last week, Unite Group had several positive announcements to make. The group has a large waiting list due to a shortage of accommodation built close to university campuses. The income from property that Unite Group does earn is expected to confidently climb by almost 5% as it looks to pass costs on to the consumer.

With a short supply of university accommodation, it seems safe to expect that students will absorb rent increases, which will be a positive for share price growth.

Unite Group currently has a respectable dividend yield of 3.2%.

However, its dividend track record is not a stable one and its share price growth in the long term is heavily reliant on the popularity of university education.

Conclusion

I think both stocks are well positioned to potentially outstrip inflation over the next few years. Both stocks have reliable income at present. The goods and services offered by both British American Tobacco and Unite Group are experiencing demand that will be difficult to shake off.

I recently added both of these stocks to my portfolio with a £1,000 position in each of them.

Dan Coates owns shares in British American Tobacco and Unite Group. The Motley Fool UK has recommended British American Tobacco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »